Cargando…

Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience

PURPOSE: Complementary and alternative medicine (CAM) has been popular among patients with cancer for several decades. The objectives of this study were to evaluate the prevalence of CAM use and to identify the factors affecting CAM use in a large patient cohort seen at a comprehensive cancer center...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalcin, Suayib, Hurmuz, Pervin, McQuinn, Lacey, Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180833/
https://www.ncbi.nlm.nih.gov/pubmed/30241173
http://dx.doi.org/10.1200/JGO.2016.008896
_version_ 1783362292840136704
author Yalcin, Suayib
Hurmuz, Pervin
McQuinn, Lacey
Naing, Aung
author_facet Yalcin, Suayib
Hurmuz, Pervin
McQuinn, Lacey
Naing, Aung
author_sort Yalcin, Suayib
collection PubMed
description PURPOSE: Complementary and alternative medicine (CAM) has been popular among patients with cancer for several decades. The objectives of this study were to evaluate the prevalence of CAM use and to identify the factors affecting CAM use in a large patient cohort seen at a comprehensive cancer center in Turkey. PATIENTS AND METHODS: An investigator-designed survey was completed by volunteer patients who visited the outpatient clinic in the medical oncology department. CAM use encompassed pharmacologic agents including vitamins, dietary supplements, and herbal products or nonpharmacologic methods like prayer, meditation, hypnosis, massage, or acupuncture. RESULTS: Of 1,499 patients who answered the survey, 1,433 (96%) used nonpharmacologic CAM and 60 (4%) used pharmacologic CAM (pCAM). The most frequent types of CAM used were prayer (n = 1,433) followed by herbal products (n = 42). pCAM use was not significantly associated with age (P = .63), sex (P = .15), diagnosis (P = .15), or income level (P = .09). However, it was significantly associated with the level of education (P = .0067) and employment status (P < .001). Patients with higher education levels used more pCAM products (P = .025). Among 60 pCAM users, six patients (10%) used pCAM for more than 2 years and 22 (36%) did not consult their physicians about their pCAM use. Only nine patients (15%) reported unpleasant adverse effects related to pCAM. CONCLUSION: Although CAM use was high among our patients, prevalence of pCAM use was lower than expected. Patients with higher education levels tended to use more pCAM.
format Online
Article
Text
id pubmed-6180833
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-61808332018-11-13 Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience Yalcin, Suayib Hurmuz, Pervin McQuinn, Lacey Naing, Aung J Glob Oncol ORIGINAL REPORTS PURPOSE: Complementary and alternative medicine (CAM) has been popular among patients with cancer for several decades. The objectives of this study were to evaluate the prevalence of CAM use and to identify the factors affecting CAM use in a large patient cohort seen at a comprehensive cancer center in Turkey. PATIENTS AND METHODS: An investigator-designed survey was completed by volunteer patients who visited the outpatient clinic in the medical oncology department. CAM use encompassed pharmacologic agents including vitamins, dietary supplements, and herbal products or nonpharmacologic methods like prayer, meditation, hypnosis, massage, or acupuncture. RESULTS: Of 1,499 patients who answered the survey, 1,433 (96%) used nonpharmacologic CAM and 60 (4%) used pharmacologic CAM (pCAM). The most frequent types of CAM used were prayer (n = 1,433) followed by herbal products (n = 42). pCAM use was not significantly associated with age (P = .63), sex (P = .15), diagnosis (P = .15), or income level (P = .09). However, it was significantly associated with the level of education (P = .0067) and employment status (P < .001). Patients with higher education levels used more pCAM products (P = .025). Among 60 pCAM users, six patients (10%) used pCAM for more than 2 years and 22 (36%) did not consult their physicians about their pCAM use. Only nine patients (15%) reported unpleasant adverse effects related to pCAM. CONCLUSION: Although CAM use was high among our patients, prevalence of pCAM use was lower than expected. Patients with higher education levels tended to use more pCAM. American Society of Clinical Oncology 2017-04-18 /pmc/articles/PMC6180833/ /pubmed/30241173 http://dx.doi.org/10.1200/JGO.2016.008896 Text en © 2017 by American Society of Clinical Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle ORIGINAL REPORTS
Yalcin, Suayib
Hurmuz, Pervin
McQuinn, Lacey
Naing, Aung
Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title_full Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title_fullStr Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title_full_unstemmed Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title_short Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience
title_sort prevalence of complementary medicine use in patients with cancer: a turkish comprehensive cancer center experience
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180833/
https://www.ncbi.nlm.nih.gov/pubmed/30241173
http://dx.doi.org/10.1200/JGO.2016.008896
work_keys_str_mv AT yalcinsuayib prevalenceofcomplementarymedicineuseinpatientswithcanceraturkishcomprehensivecancercenterexperience
AT hurmuzpervin prevalenceofcomplementarymedicineuseinpatientswithcanceraturkishcomprehensivecancercenterexperience
AT mcquinnlacey prevalenceofcomplementarymedicineuseinpatientswithcanceraturkishcomprehensivecancercenterexperience
AT naingaung prevalenceofcomplementarymedicineuseinpatientswithcanceraturkishcomprehensivecancercenterexperience